Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Development of radiation therapy optimization.

¹Department of Medical Radiation Physics, Karolinska Institutet and Stockholm University, Sweden.

Acta Oncologica (Stockholm, Sweden)

|November 28, 2000

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Specification of Dose Delivery in Radiation Therapy. Recommendations by the Nordic Association of Clinical Physics (NACP).

Acta oncologica (Stockholm, Sweden)·2017

Same author

A comparative analysis of radiobiological models for cell surviving fractions at high doses.

Technology in cancer research & treatment·2012

Same author

Radiobiological description of the LET dependence of the cell survival of oxic and anoxic cells irradiated by carbon ions.

Journal of radiation research·2012

Same author

Production of clinically useful positron emitter beams during carbon ion deceleration.

Physics in medicine and biology·2011

Same author

Analytical description of the LET dependence of cell survival using the repairable-conditionally repairable damage model.

Radiation research·2010

Same author

Analytical theory for the fluence, planar fluence, energy fluence, planar energy fluence and absorbed dose of primary particles and their fragments in broad therapeutic light ion beams.

Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB)·2009

Same journal

Overall survival following palliative immune checkpoint inhibitor treatment according to ECOG performance status: a large registry-based study.

Acta oncologica (Stockholm, Sweden)·2026

Same journal

Pathological characteristics and prognosis of very young patients with early breast cancer: a comparative analysis with older patients.

Acta oncologica (Stockholm, Sweden)·2026

Same journal

Recent survival trends in the most fatal cancers in the Nordic countries: gains in some but not in all.

Acta oncologica (Stockholm, Sweden)·2026

Same journal

First-in-human quantitative [¹⁵O]H₂O PET imaging of tumour blood flow at rest and during exercise in lymphoma patients.

Acta oncologica (Stockholm, Sweden)·2026

Same journal

Starshot field configuration in the linac isocentre size determination: a comparison of film and electronic portal imaging device measurements.

Acta oncologica (Stockholm, Sweden)·2026

Same journal

Perspectives on artificial intelligence-generated chronic disease risk predictions in early breast cancer: an international survey among radiation oncologists.

Acta oncologica (Stockholm, Sweden)·2026

See all related articles

Radiobiologically optimized intensity-modulated radiation therapy significantly improves cancer treatment outcomes by optimizing dose delivery to tumors and critical organs. This advanced technique enhances patient care and is poised to become a vital clinical tool.

Area of Science:

Radiation Oncology
Medical Physics
Radiobiology

Background:

Advanced tumors present significant radiobiological challenges in treatment.
Current treatment strategies may not fully optimize dose-response relationships.

Purpose of the Study:

To present solutions to radiobiological problems in advanced tumor treatment.
To highlight the benefits of radiobiologically optimized intensity-modulated radiation therapy (IMRT).

Main Methods:

Optimizing dose and dose per fraction to tumors.
Minimizing dose to organs at risk.
Reducing overall treatment time and fraction number.
Comparing advanced IMRT techniques and equipment costs.

Main Results:

Related Experiment Videos

Considerable improvements in treatment outcomes achieved through optimized IMRT.
Increased tumor dose and dose per fraction while maintaining or reducing dose to organs at risk.
Reduced treatment time and fraction count.

Conclusions:

Radiobiologically optimized IMRT is a promising clinical tool for advanced tumors.
It enhances collaboration among radiation oncology professionals.
It facilitates data feedback for improved dose-response accuracy and future treatment optimization.
Long-term cost-effectiveness is predicted with full integration of new technologies.